Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
| Autor: | Alvarez, E., Brady, W., Walker, J., Rotmensch, J., Zhou, X., Kendrick, J., Yamada, S., Aghajanian, C. |
|---|---|
| Zdroj: | In Gynecologic Oncology March 2012 125 Supplement 1:S17-S17 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect